Biomerica (BMRA) Return on Capital Employed (2011 - 2026)
Biomerica recorded quarterly Return on Capital Employed of 137.43% in Q1 2026, down 26.47% quarter-over-quarter from 108.67% in Q4 2025, and down 18174.0% year-over-year from N/an in Q1 2025.
Biomerica's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 137.43% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 18174.0% year-over-year to 137.43%; the TTM figure through Feb 2026 stood at 137.43% (down 18174.0% YoY), while the FY2025 annual figure was 87.67%, down 10059.0% from the prior year.
- Return on Capital Employed came in at 137.43% for Q1 2026 at Biomerica, down from 108.67% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 44.31% in Q1 2025 to a low of 137.43% in Q1 2026.
- A 5-year average of 53.12% and a median of 59.11% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed soared 11771 bps in 2025 and tumbled 18174 bps in 2026, its largest moves.
- Biomerica's Return on Capital Employed stood at 64.25% in 2022, then climbed by 8 bps to 59.11% in 2023, then jumped by 151 bps to 30.28% in 2024, then slumped by 459 bps to 108.67% in 2025, then dropped by 26 bps to 137.43% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 137.43%, 108.67%, and 103.79% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | -137.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -137.43% |
| Nov 30, 2025 | -108.67% |
| Aug 31, 2025 | -103.79% |
| May 31, 2025 | -104.36% |
| Feb 28, 2025 | 44.31% |
| Nov 30, 2024 | 30.28% |
| Aug 31, 2024 | 17.31% |
| May 31, 2024 | 16.41% |
| Feb 29, 2024 | -73.40% |
| Nov 30, 2023 | -59.11% |
| Aug 31, 2023 | -52.81% |
| May 31, 2023 | -76.95% |
| Feb 28, 2023 | -93.21% |
| Nov 30, 2022 | -64.25% |
| Aug 31, 2022 | -53.56% |
| May 31, 2022 | -36.40% |
| Feb 28, 2022 | -47.43% |
| Nov 30, 2021 | -77.87% |
| Aug 31, 2021 | -70.11% |
| May 31, 2021 | -64.32% |
| Feb 28, 2021 | -24.35% |
| Nov 30, 2020 | -13.59% |
| Aug 31, 2020 | -3.96% |
| May 31, 2020 | 4.99% |
| Feb 29, 2020 | 4.04% |
| Nov 30, 2019 | 8.96% |
| Aug 31, 2019 | 9.59% |
| May 31, 2019 | 12.78% |
| Feb 28, 2019 | -55.43% |
| Nov 30, 2018 | -46.13% |
| Aug 31, 2018 | -40.23% |
| Aug 31, 2017 | -25.69% |
| May 31, 2017 | -20.23% |
| Feb 28, 2017 | -17.95% |
| Nov 30, 2016 | -16.42% |
| Aug 31, 2016 | -15.63% |
| May 31, 2016 | -15.62% |
| Feb 29, 2016 | 5.17% |
| Nov 30, 2015 | 7.47% |
| Aug 31, 2015 | 6.72% |
| May 31, 2015 | 4.14% |
| Feb 28, 2015 | -12.37% |
| Nov 30, 2014 | -9.05% |
| Aug 31, 2014 | -8.41% |
| May 31, 2014 | -7.68% |
| Feb 28, 2014 | -12.73% |
| Nov 30, 2013 | -14.19% |
| Aug 31, 2013 | -5.24% |
| May 31, 2013 | 3.23% |
| Feb 28, 2013 | 10.11% |
| Nov 30, 2012 | 13.77% |
| Aug 31, 2012 | 13.82% |
| May 31, 2012 | 10.17% |
| Feb 29, 2012 | 9.25% |
| Nov 30, 2011 | 8.01% |
| Aug 31, 2011 | -0.07% |